New chemo injection method aims to boost survival in pancreatic cancer
NCT ID NCT07429643
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether injecting chemotherapy directly into a pancreatic tumor using an endoscope (EUS-guided) plus standard chemo works better than standard chemo alone. About 20 adults with locally advanced pancreatic cancer will take part. The goal is to see if the combination slows cancer growth and improves response rates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New personalized vaccine takes on tough cancers
- New radiation bead treatment targets Hard-to-Treat pancreatic tumors
- New catheter targets pancreatic cancer tumors directly
- New hope for pancreatic cancer? drug combo trial launches
- New drug cocktail shows promise against Hard-to-Treat cancers
- New radiation approach aims to shrink pancreatic tumors in just five sessions